serine and pd 123319

serine has been researched along with pd 123319 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nagane, Y; Obara, D; Terayama, Y; Utsugisawa, K; Utsugisawa, T	1
Andreozzi, F; Laino, I; Martino, F; Musca, D; Perticone, F; Perticone, M; Presta, I; Sciacqua, A; Sesti, G; Tassone, EJ	1

Other Studies

2 other study(ies) available for serine and pd 123319

Article	Year
Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKCdelta inhibition. Brain research. Molecular brain research, 2005, Apr-27, Volume: 135, Issue:1-2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Death; Cell Hypoxia; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Imidazoles; In Situ Nick-End Labeling; Mice; PC12 Cells; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Pyridines; Rats; Serine; Tetrazoles; Time Factors; Transfection	2005
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. Atherosclerosis, 2011, Volume: 219, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Cells, Cultured; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Losartan; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Serine; Signal Transduction; Tyrosine	2011

Article

Year

Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKCdelta inhibition.

Brain research. Molecular brain research, 2005, Apr-27, Volume: 135, Issue:1-2

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Death; Cell Hypoxia; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Imidazoles; In Situ Nick-End Labeling; Mice; PC12 Cells; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Pyridines; Rats; Serine; Tetrazoles; Time Factors; Transfection

2005

Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs.

Atherosclerosis, 2011, Volume: 219, Issue:2

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Cells, Cultured; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Losartan; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Serine; Signal Transduction; Tyrosine

2011